Market Insights Health OTC Pharmaceuticals

Cold & Cough Remedies - Egypt

Egypt

In Egypt, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to US$0.32bn.
It is projected that the market will experience an annual growth rate of 13.40% (CAGR 2024-2029).
Comparatively, the in the United States generates the highest revenue in this market, with US$11,190.00m in 2024.
Taking into account the total population, per person revenues reach US$2.79 in 2024.
Despite a growing awareness of natural remedies, Egyptians still heavily rely on traditional OTC cold and cough remedies.

Key regions: Australia, Japan, India, Brazil, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Cold & Cough Remedies market in Egypt has been experiencing steady growth in recent years.

Customer preferences: Egyptian consumers have shown a growing preference for over-the-counter cold and cough remedies. This can be attributed to several factors. Firstly, the convenience of purchasing these remedies without a prescription appeals to busy individuals who may not have the time to visit a doctor for a minor cold or cough. Secondly, the affordability of over-the-counter remedies compared to prescription medications makes them a more accessible option for many consumers. Additionally, the increasing awareness and education about self-care and the importance of early treatment for cold and cough symptoms have also contributed to the rising demand for these remedies.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Egypt is the growing popularity of natural and herbal remedies. Consumers are becoming more conscious about the ingredients in the products they use and are seeking alternatives to traditional pharmaceuticals. This trend is driven by a desire for more natural and holistic approaches to healthcare. As a result, companies in the market are introducing products that contain natural and herbal ingredients, catering to this growing demand.Another trend in the market is the increasing availability of cold and cough remedies in various formats. While traditional tablets and syrups remain popular, there has been a rise in the availability of alternative formats such as lozenges, nasal sprays, and inhalers. These alternative formats offer convenience and ease of use, catering to different consumer preferences.

Local special circumstances: One of the unique aspects of the Egyptian market is the prevalence of air pollution, particularly in urban areas. This has led to an increase in respiratory issues, including colds and coughs, among the population. As a result, there is a higher demand for cold and cough remedies to alleviate these symptoms. Additionally, the country's large population and high population density contribute to the overall demand for these products.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies market in Egypt can also be attributed to several macroeconomic factors. Firstly, the country's growing middle class has more disposable income, allowing them to spend on healthcare products. This has led to an increase in overall healthcare expenditure, including spending on over-the-counter remedies. Secondly, the government's efforts to improve access to healthcare and promote self-care have also contributed to the growth of the market. These initiatives have increased awareness about the importance of early treatment and have made healthcare products more accessible to the general population.In conclusion, the Cold & Cough Remedies market in Egypt is experiencing steady growth due to customer preferences for over-the-counter remedies, the popularity of natural and herbal products, and the availability of alternative formats. The local special circumstances, such as air pollution and population density, contribute to the demand for these products. Additionally, underlying macroeconomic factors, such as the growing middle class and government initiatives, support the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.